Cambridge structural database reaches 750,000 entry milestone
16 December 2014 | By The Cambridge Crystallographic Data Centre
Essential resource to scientists around the world reaches historic record...
List view / Grid view
News
Abbott commences tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022
16 December 2014 | By Abbott
Abbott announced that its wholly-owned subsidiary, Abbott Laboratories (Chile) Holdco (Dos) SpA, a Chilean corporation ("ALH"), has commenced a tender offer (the "U.S. Notes Offer"), in which it is offering to purchase for cash any and all of the outstanding $300 million aggregate principal amount of 5.125% Senior Notes due…
Line dancing bacteria win the 2014 Dolomite and Lab on a Chip Video Competition
16 December 2014 | By kdm communications
The inaugural MicroTAS Video Competition, run by microfluidics specialist Dolomite and Lab on a Chip, and supported by the Chemical and Biological Microsystems Society, saw first prize awarded to an enterprising – and highly creative – entry submitted by Tijmen Hageman from the Korean Institute of Science and Technology (KIST)…
Orange and USAID join forces to boost mHealth innovations across Africa
15 December 2014 | By Orange
The U.S. Agency for International Development and global telecommunications operator Orange announced a new alliance to develop innovations in mobile health (mHealth) at the Global mHealth Forum in Washington, DC...
UK patients with moderately to severely active ulcerative colitis gain access to a range of biologic therapies on the NHS
15 December 2014 | By MSD
NICE says ‘yes’ to REMICADE® (infliximab), HUMIRA® (adalimumab) and SIMPONI® (golimumab) for adult patients with moderately to severely active ulcerative colitis...
Abbott completes acquisition of Veropharm
15 December 2014 | By Abbott
Abbott announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer...
Biotech-Cluster Rhine-Neckar (BioRN) leads InnoLife consortium to success in the competition Healthy Living and Active Ageing of the European Institute for Innovation and Technology (EIT)
15 December 2014 | By BioRN
Future role as German coordination centre for the largest European cooperation project in the health sector to date...
Ethiopia will receive 13 million praziquantel tablets in 2015
12 December 2014 | By Merck KGaA
Merck supports the World Health Organization (WHO) to fight the parasitic worm disease schistosomiasis in Africa...
Changes in Roche Board of Directors and enlarged Corporate Executive Committee
12 December 2014 | By Roche
At its December meeting, the Board of Directors (BoD) of Roche Holding recommended first proposals for approval by the AGM, scheduled for 3 March 2015...
Janssen and USAID collaborate to expand access to anti-multidrug-resistant tuberculosis (MDR-TB) compound
12 December 2014 | By Johnson & Johnson
Memorandum of Understanding signed to address the global health threat of antibiotic-resistant bacteria...
Patent cliff means pharmaceutical companies will lose $65 billion by 2019, says GlobalData
11 December 2014 | By GlobalData
Pharmaceutical companies will suffer an estimated $65 billion drop in sales by 2019 due to the patent expiries of several leading drugs, according to research and consulting firm GlobalData...
Otsuka and Lundbeck´s brexpiprazole demonstrates statistically significant effects in New Phase III Studies in adult patients with schizophrenia
11 December 2014 | By H. Lundbeck A/S
... presented at the American College of Neuropsychopharmacology annual meeting.
Abbott’s pioneering, infectious disease testing platform, IRIDICA, now available in Europe
11 December 2014 | By Abbott
Abbott announced its innovative diagnostic platform, known as IRIDICA, is now available in Europe and other CE-Mark recognized countries...
Gielad presents follow-up data from idelalisib (zydelig®) registrational studies in patients with chronic lymphocytic leukemia, follicular lymphoma and small lymphocytic lymphoma
11 December 2014 | By Gilead Sciences
Results describing long-term safety and disease control presented at the 56th American Society of Hematology Annual Meeting...
Bristol-Myers Squibb announces dividend
10 December 2014 | By Bristol-Myers Squibb Company
The Board of Directors of Bristol-Myers Squibb Company declared a quarterly dividend of thirty-seven cents ($0.37) per share on the $.10 par value Common Stock of the corporation...
